Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Pediatric Neurology

Managing Epilepsy and Seizures in Aicardi Syndrome

At a Glance

Aicardi syndrome epilepsy often begins in infancy and may be difficult to control. Treatment focuses on reducing seizure frequency and severity, preventing injuries, and improving quality of life through medicines, a supervised ketogenic diet, VNS, or selected surgery.

Managing epilepsy is often the most significant challenge for families living with Aicardi syndrome. Because the condition involves widespread changes in how the brain is formed, the seizures that result are typically complex and difficult to control with medication alone [1][2]. While achieving total “seizure freedom” is uncommon in Aicardi syndrome, the goal of treatment is often focused on seizure-reduction and symptom-directed treatment—meaning the focus is on reducing the number and severity of seizures, preventing injuries, and improving your child’s quality of life [3][4].

The Typical Seizure Journey

For most children with Aicardi syndrome, epilepsy begins very early, often within the first few months of life. The median age for the first seizure is approximately 2.2 months [5].

  1. Infantile Spasms: The first sign is usually infantile spasms (or epileptic spasms). These are sudden, brief stiffening of the body, arms, or legs that often occur in “clusters” when the child is waking up or falling asleep [6]. Suspected infantile spasms are time-sensitive and require prompt pediatric epilepsy assessment and video-EEG confirmation. Do not wait for a routine visit if you suspect these spasms. Evidence-based first-line approaches commonly include hormonal treatment (such as ACTH or prednisolone) and/or vigabatrin, depending on the clinical situation. Early treatment matters.
  2. Evolution to Drug Resistance: Over time, these spasms often evolve into other seizure types, such as tonic seizures (sudden stiffening) or “drop attacks” [4].
  3. Refractory Epilepsy: Most children (over 90%) develop refractory epilepsy, also known as drug-resistant epilepsy. This means the seizures continue even after trying two or more appropriately chosen and dosed antiseizure medications [2][4].

The Ketogenic Diet

When medications do not provide enough relief, many families turn to the ketogenic diet. This is a medical, high-fat, low-carbohydrate diet that changes how the brain uses energy. It must be managed strictly by a specialized medical team, including a neurologist and a dietitian. It carries serious safety considerations, including screening for contraindications, medication-carbohydrate issues, hypoglycemia, dehydration, acidosis, kidney stones, and nutrient deficiencies.

Research specifically looking at children with Aicardi syndrome found encouraging, though preliminary, results for the ketogenic diet:

  • Response Rate: In a small study of 15 patients, 67% (10 out of 15) achieved at least a 50% reduction in their seizures after three months on the diet [3]. Because this study was small, this percentage should not be viewed as an exact predicted success rate for every individual child.
  • High Success: About 20% of those children saw a 90% or greater reduction in seizures [3].
  • Reality Check: While the diet can significantly lower the number of seizures, it rarely stops them entirely. In the same study, only one child achieved temporary seizure freedom [3]. Families must not attempt the diet without a specialized epilepsy-nutrition program.

Surgical and Adjunctive Options

If the ketogenic diet and medications are not enough, your medical team may discuss surgical interventions. These are typically viewed as options requiring comprehensive epilepsy-center evaluation to reduce the seizure burden rather than a “cure” for epilepsy.

Vagus Nerve Stimulation (VNS)

A Vagus Nerve Stimulator (VNS) is a small device surgically implanted under the skin of the chest. A wire travels from the device to the vagus nerve in the neck, sending regular, mild pulses of electricity to the brain to help calm seizure activity [7]. While data specific to Aicardi syndrome is limited, VNS is a common adjunctive option for children with drug-resistant epilepsy to help reduce seizure frequency and shorten recovery time after a seizure [7].

Corpus Callosotomy

A corpus callosotomy is a procedure where the connection between the two halves of the brain is severed. In Aicardi syndrome, where the corpus callosum is already partially or completely missing, this surgery is only considered in highly specific, individualized cases [4].

  • Goal: The main goal is to stop seizures from spreading from one side of the brain to the other, which can prevent sudden “drop attacks” that cause falls and injuries [8].
  • Candidacy: This is most often discussed for children who have a partially formed corpus callosum and suffer from frequent, disabling falls [4]. A person with complete agenesis has no normal corpus callosum to sever.

Measuring Success

In Aicardi syndrome, success is often measured by more than just a “seizure count.” Families and doctors look at whether a treatment helps the child be more alert, improves their ability to participate in therapies, or reduces the need for emergency room visits. Because the burden of malformations in the brain is high, the management of epilepsy is a lifelong process that requires frequent adjustments and a dedicated care team [1][9].

Common questions in this guide

When do seizures usually begin in Aicardi syndrome?
Epilepsy often starts in the first few months of life, and infantile spasms are a common first seizure type. Spasms can happen in clusters around waking or falling asleep; suspected spasms need prompt assessment by a pediatric epilepsy team and video-EEG confirmation rather than waiting for a routine visit.
What does drug-resistant epilepsy mean for a child with Aicardi syndrome?
Drug-resistant epilepsy means seizures continue after two appropriately chosen and correctly dosed antiseizure medicines have been tried. In Aicardi syndrome, many children develop this pattern, so care may include a specialized epilepsy center and options beyond medication.
Can a ketogenic diet reduce seizures in Aicardi syndrome?
A ketogenic diet reduced seizures by at least half in 10 of 15 children in one small study, but it did not usually stop seizures completely. It must be started and monitored by a specialized epilepsy and nutrition team because it can cause low blood sugar, dehydration, acid buildup, kidney stones, nutrient deficiencies, and medication-related problems.
What is VNS, and could it help with Aicardi syndrome epilepsy?
Vagus nerve stimulation uses a small implanted device to send regular, mild electrical pulses through the vagus nerve to help reduce seizure frequency and shorten recovery after seizures. Evidence specific to Aicardi syndrome is limited, and VNS is generally considered an add-on treatment for drug-resistant epilepsy rather than a cure.
Could corpus callosotomy help prevent drop attacks?
Corpus callosotomy separates remaining connections between the brain’s two hemispheres to limit seizure spread and may reduce disabling drop attacks. In Aicardi syndrome, it is considered only in selected cases, especially when part of the corpus callosum is present; a completely absent corpus callosum cannot be severed.
How do doctors measure whether epilepsy treatment is helping?
Success may mean fewer or less severe seizures, fewer injuries or emergency visits, better alertness, and greater participation in therapy, even if seizures do not stop completely. The treatment team can use these goals, along with seizure tracking and side effects, to adjust the plan over time.
How can we prepare for seizure clusters or prolonged seizures?
Ask the child’s epilepsy team to create a written seizure action plan that identifies the child’s seizure patterns, explains when prescribed emergency medicine should be used, and states when urgent help is needed. Review the plan regularly with the medical team and update it when the treatment plan changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given that my child's seizures have not responded to several medications, is it time to consider a referral to a level 4 pediatric epilepsy center?
  2. 2.Based on the small study's responder rate, is my child a good candidate for the ketogenic diet, and what are the specific safety risks we would need to monitor?
  3. 3.Does my child's brain structure, specifically the degree of corpus callosum formation, make them a candidate for a corpus callosotomy?
  4. 4.What are the specific risks and expected benefits of Vagus Nerve Stimulation (VNS) for a child with Aicardi syndrome?
  5. 5.Can we develop a formal 'Seizure Action Plan' for seizure clusters or prolonged events that specifies when to use emergency medication?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Agenesis of the Corpus Callosum and Aicardi Syndrome: A Neuroimaging and Clinical Comparison.

    Govil-Dalela T, Kumar A, Agarwal R, Chugani HT

    Pediatric neurology 2017; (68()):44-48.e2 doi:10.1016/j.pediatrneurol.2016.12.002.

    PMID: 28214165
  2. 2

    Basal Ganglia Dysmorphism in Patients With Aicardi Syndrome.

    Masnada S, Pichiecchio A, Formica M, et al.

    Neurology 2021; (96(9)):e1319-e1333 doi:10.1212/WNL.0000000000011237.

    PMID: 33277420
  3. 3

    Ketogenic Diet Therapy for Epilepsy Associated With Aicardi Syndrome.

    Sanchez MAR, Cervenka MC, Bessone SK, Kossoff EH

    Journal of child neurology 2021; (36(11)):1007-1010 doi:10.1177/08830738211023335.

    PMID: 34240629
  4. 4

    Corpus Callosotomy for Refractory Epilepsy in Aicardi Syndrome: Case Report and Focused Review of the Literature.

    Bernstock JD, Olsen HE, Segar D, et al.

    World neurosurgery 2020; (142()):450-455 doi:10.1016/j.wneu.2020.06.230.

    PMID: 32652281
  5. 5

    Systematic quantitative modeling of the natural history of Aicardi syndrome: A cross sectional study of 245 published cases.

    Urban OY, Driedger JH, Garbade SF, et al.

    Orphanet journal of rare diseases 2024; (19(1)):457 doi:10.1186/s13023-024-03375-8.

    PMID: 39633384
  6. 6

    Microphthalmia and Infantile Spasms Leading to the Diagnosis of Aicardi Syndrome: A Case Report and Literature Review of a Rare Entity.

    Amanallah MR, Chraa M, Louhab N, Balili K

    Cureus 2025; (17(12)):e99822 doi:10.7759/cureus.99822.

    PMID: 41573467
  7. 7

    The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis.

    Hajtovic S, LoPresti MA, Zhang L, et al.

    Journal of neurosurgery. Pediatrics 2022; (29(6)):667-680 doi:10.3171/2022.1.PEDS222.

    PMID: 35303699
  8. 8

    Rates and predictors of seizure outcome after corpus callosotomy for drug-resistant epilepsy: a meta-analysis.

    Chan AY, Rolston JD, Lee B, et al.

    Journal of neurosurgery 2019; (130(4)):1193-1202 doi:10.3171/2017.12.JNS172331.

    PMID: 29999448
  9. 9

    Aicardi syndrome and cognitive abilities: A report of five cases.

    Tuft M, Østby Y, Nakken KO, Lund C

    Epilepsy & behavior : E&B 2017; (73()):161-165 doi:10.1016/j.yebeh.2017.05.002.

    PMID: 28641168

This page explains epilepsy management options in Aicardi syndrome for informational purposes only and does not constitute medical advice. Your child’s pediatric neurologist or epilepsy team should guide urgent evaluation, medicines, dietary therapy, and surgical decisions.

Get notified when new evidence is published on Aicardi syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.